225 related articles for article (PubMed ID: 25666587)
21. Cost-Effectiveness of Reduced Waiting Time for Head and Neck Cancer Patients due to a Lean Process Redesign.
Simons PA; Ramaekers B; Hoebers F; Kross KW; Marneffe W; Pijls-Johannesma M; Vandijck D
Value Health; 2015 Jul; 18(5):587-96. PubMed ID: 26297086
[TBL] [Abstract][Full Text] [Related]
22. Long-term swallowing, trismus, and speech outcomes after combined chemoradiotherapy and preventive rehabilitation for head and neck cancer; 10-year plus update.
Karsten RT; van der Molen L; Hamming-Vrieze O; van Son RJJH; Hilgers FJM; van den Brekel MWM; Stuiver MM; Smeele LE
Head Neck; 2020 Aug; 42(8):1907-1918. PubMed ID: 32112600
[TBL] [Abstract][Full Text] [Related]
23. Two-year results of a prospective preventive swallowing rehabilitation trial in patients treated with chemoradiation for advanced head and neck cancer.
van der Molen L; van Rossum MA; Rasch CR; Smeele LE; Hilgers FJ
Eur Arch Otorhinolaryngol; 2014 May; 271(5):1257-70. PubMed ID: 23892729
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of long term (10-years+) dysphagia and trismus in patients treated with concurrent chemo-radiotherapy for advanced head and neck cancer.
Kraaijenga SA; Oskam IM; van der Molen L; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW
Oral Oncol; 2015 Aug; 51(8):787-94. PubMed ID: 26027851
[TBL] [Abstract][Full Text] [Related]
25. Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluation.
Retèl VP; Steuten LMG; Geukes Foppen MH; Mewes JC; Lindenberg MA; Haanen JBAG; van Harten WH
BMC Cancer; 2018 Sep; 18(1):895. PubMed ID: 30219040
[TBL] [Abstract][Full Text] [Related]
26. Significant preservation of swallowing function in chemoradiotherapy for advanced head and neck cancer by prophylactic swallowing exercise.
Ohba S; Yokoyama J; Kojima M; Fujimaki M; Anzai T; Komatsu H; Ikeda K
Head Neck; 2016 Apr; 38(4):517-21. PubMed ID: 25351675
[TBL] [Abstract][Full Text] [Related]
27. Adherence to a Prophylactic Swallowing Therapy Program During (Chemo) Radiotherapy: Impact of Service-Delivery Model and Patient Factors.
Wall LR; Ward EC; Cartmill B; Hill AJ; Porceddu SV
Dysphagia; 2017 Apr; 32(2):279-292. PubMed ID: 27844152
[TBL] [Abstract][Full Text] [Related]
28. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
[TBL] [Abstract][Full Text] [Related]
29. Treating trismus: A prospective study on effect and compliance to jaw exercise therapy in head and neck cancer.
Pauli N; Andréll P; Johansson M; Fagerberg-Mohlin B; Finizia C
Head Neck; 2015 Dec; 37(12):1738-44. PubMed ID: 24986051
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness analysis of an 18-week exercise programme for patients with breast and colon cancer undergoing adjuvant chemotherapy: the randomised PACT study.
May AM; Bosch MJ; Velthuis MJ; van der Wall E; Steins Bisschop CN; Los M; Erdkamp F; Bloemendal HJ; de Roos MA; Verhaar M; Ten Bokkel Huinink D; Peeters PH; de Wit GA
BMJ Open; 2017 Mar; 7(3):e012187. PubMed ID: 28264824
[TBL] [Abstract][Full Text] [Related]
31. Study protocol for a randomized controlled trial: prophylactic swallowing exercises in head-and-neck cancer patients treated with (chemo)radiotherapy (PRESTO trial).
Baudelet M; Van den Steen L; Duprez F; De Bodt M; Deschuymer S; Goeleven A; Hutsebaut I; Mariën S; Meersschout S; Nevens D; Nuyts S; Peeters M; Specenier P; Van den Brekel M; van der Molen L; Vandenbruaene C; Vanderveken O; Van Dinther J; Van Laer C; Vauterin T; Verstraete H; Van Nuffelen G;
Trials; 2020 Mar; 21(1):237. PubMed ID: 32122397
[TBL] [Abstract][Full Text] [Related]
32. Protons in head-and-neck cancer: bridging the gap of evidence.
Ramaekers BL; Grutters JP; Pijls-Johannesma M; Lambin P; Joore MA; Langendijk JA
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1282-8. PubMed ID: 23273998
[TBL] [Abstract][Full Text] [Related]
33. Cost effectiveness of neoadjuvant chemotherapy in locally advanced operable head and neck cancer followed by surgery and postoperative radiotherapy: a Markov model-based decision analysis.
Himmel M; Hartmann M; Guntinas-Lichius O
Oncology; 2013; 84(6):336-41. PubMed ID: 23652024
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation.
Antunes HS; Schluckebier LF; Herchenhorn D; Small IA; Araújo CM; Viégas CM; Rampini MP; Ferreira EM; Dias FL; Teich V; Teich N; Ferreira CG
Oral Oncol; 2016 Jan; 52():85-90. PubMed ID: 26559740
[TBL] [Abstract][Full Text] [Related]
35. Economic evaluation of a tight-control treatment strategy using an imaging device (handscan) for monitoring joint inflammation in early rheumatoid arthritis.
Nair SC; Welsing PM; Jacobs JW; van Laar JM; Rensen WH; Ardine de Wit G; Bijlsma JW; Lafeber FP
Clin Exp Rheumatol; 2015; 33(6):831-8. PubMed ID: 26343274
[TBL] [Abstract][Full Text] [Related]
36. The use of intensive radiological assessments in routine surveillance after treatment for head and neck cancer: An economic evaluation.
Meregaglia M; Cairns J; Licitra L; Bossi P
Eur J Cancer; 2018 Apr; 93():89-98. PubMed ID: 29477796
[TBL] [Abstract][Full Text] [Related]
37. Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review.
van der Molen L; van Rossum MA; Burkhead LM; Smeele LE; Hilgers FJ
Eur Arch Otorhinolaryngol; 2009 Jun; 266(6):889-900. PubMed ID: 18825400
[TBL] [Abstract][Full Text] [Related]
38. Using experience-based co-design to improve the pre-treatment care pathway for people diagnosed with head and neck cancer.
Brady GC; Goodrich J; Roe JWG
Support Care Cancer; 2020 Feb; 28(2):739-745. PubMed ID: 31139929
[TBL] [Abstract][Full Text] [Related]
39. Cost-Effectiveness Analysis in Telehealth: A Comparison between Home Telemonitoring, Nurse Telephone Support, and Usual Care in Chronic Heart Failure Management.
Grustam AS; Severens JL; De Massari D; Buyukkaramikli N; Koymans R; Vrijhoef HJM
Value Health; 2018 Jul; 21(7):772-782. PubMed ID: 30005749
[TBL] [Abstract][Full Text] [Related]
40. Cost-Effectiveness of Multidisciplinary Management Program and Exercise Training Program in Heart Failure.
Dang W; Yi A; Jhamnani S; Wang SY
Am J Cardiol; 2017 Oct; 120(8):1338-1343. PubMed ID: 28842145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
